✦ LIBER ✦

The combination of gemcitabine and oxaliplatin (GEM-OXAL) is feasible in patients with poor prognosis advanced non-small cell lung cancer (NSCLC). Results of a phase II study

✍ Scribed by V. Franciosi; R. Barbieri; G. Vasini; E. Aitini; C. Cacciani; R. Capra; F. Greco; C. Bozzetti; S. Cascinu

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Results of the phase I-II study of gemci

✍ Faivre, S; Monnerat, C; Raymond, E; Taieb, J; Adi Vago, N; Vicente-Azevedo, J; R 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 105 KB

Gemcitabine plus oxaliplatin combination

✍ Kakolyris, Stylianos; Ziras, Nikolaos; Vamvakas, Lambros; Varthalitis, John; Pap 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 179 KB

Combination chemotherapy with carboplati

✍ Pectasides, D.; Aspropotamitis, A.; Halikia, A.; Visvikis, A.; Antoniou, F.; Kal 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 165 KB

Phase I–II and pharmacokinetic study com

✍ S. Faivre; E. Raymond; F. Lokiec; C. Monnerat; S. Novello; P. Pautier; C. Lhommé 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 164 KB

Phase II study of oxaliplatin (L-OHP) in

✍ Monnet, I.; Brienza, S.; Voisin, S.; Gastiaburu, J.; Armand, J.P.; Cvitkovic, E. 📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 170 KB

Gemcitabine (GEM) and Vindesine (VDS) in

✍ Santo, Antonio; Genestreti, Giovenzio; Terzi, Alberto; Azzoni, Paolo; Sava, Teod 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 121 KB